Increased Employment for Patients in Remission* With Infliximab Maintenance Therapy
Overall Change of Employment Rate                     Between Baseline and Week 54
0
10
20
30
40
50
60
70
80
55%
65%
71%
76%
Full Time
Full Time or Part Time
Text Box: % Employed
% Employed
Baseline
Week 54
*At Week 54; preliminary data
Lichtenstein GR et al. Gastroenterology. 2002;122:A613. Abstract W1341.